Immatics Biotechnologies GmbH

Allemagne


 
Quantité totale PI 1 172
Rang # Quantité totale PI 1 133
Note d'activité PI 3,6/5.0    871
Rang # Activité PI 836
Symbole boursier
ISIN NL0015285941
Capitalisation 909.10004M  (EUR)
Classe Nice dominante Services scientifiques, technolo...

Brevets

Marques

874 24
112 19
102 20
21
 
Dernier brevet 2025 - Antigen binding proteins against...
Premier brevet 2001 - Use of the heat shock protein gp96
Dernière marque 2024 - SUPRAME
Première marque 2004 - IMMATICS

Industrie (Classification de Nice)

Derniers inventions, produits et services

2024 P/S Conducting of medical, scientific and clinical studies in the field of engineered T-cell receptor...
Invention Sorting with counter selection using sequence similar peptides. The present invention relates to...
Invention Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (h...
Invention Antigen binding proteins against mageb2. The present invention relates to antigen binding protei...
Invention Antigen binding proteins against mageb2. The present invention relates to antigen binding protein...
Invention Novel t cell receptors targeting melanoma-associated antigen (mage) b2 and immune therapy using t...
Invention A method of identifying mhc-binding proteins and interacting peptides in a sample. The present in...
Invention Peptides for use in immunotherapy against cancers. The present invention relates to peptides, pr...
Invention Novel peptides & combination of peptides as targets or active ingredients for use in immunotherap...
Invention Novel peptides and combination of peptides for use in immunotherapy against various tumors. A me...
Invention Novel peptides and combination of peptides for use in immunotherapy against cll and other cancers...
Invention Novel t cell receptors and immune therapy using the same. The present invention pertains to anti...
Invention Method for the absolute quantification of naturally processed hla-restricted cancer peptides. Th...
Invention Peptides displayed by hla for use in immunotherapy against different types of cancers. The inven...
Invention Transfected t-cells and t-cell receptors for use in immunotherapy against cancers. Disclosed are...
Invention Novel engineered t cell receptors and immune therapy using the same. The present invention perta...
Invention Immunotherapy against several tumors including lung cancer. A method of treating a patient who h...
Invention Amidated peptides and their deamidated counterparts displayed by non-hla-a*02 for use in immunoth...
2023 Invention Peptides and combination of peptides for use in immunotherapy against non-small cell lung cancer ...
Invention Amidated peptides and their deamidated counterparts displayed by hla-a*02 for use in immunotherap...
2022 Invention Stabilized mhc molecules. The present invention relates to a composition comprising a major hist...
Invention Selection of immune cells using peptide mhc complexes generated by conditional ligand exchange. ...
2021 P/S Bioinformatics software; graphical user interface software; artificial intelligence and machine ...
P/S Bioinformatics software; graphical user interface software; artificial intelligence and machine l...
2020 P/S Medical and veterinary preparations and articles, namely medicines for cancer treatment and natur...
P/S Pharmaceutical products, namely biological and chemical preparations for the medical treatment of...
P/S Financial planning services; financial management; financial information; financial investment br...
P/S Financial planning services; financial appraisal services; financial management; financial inform...
P/S Medical and veterinary preparations and articles, namely, medicines and natural remedies, and dia...
P/S Medical and veterinary preparations and articles, Namely medicines and natural remedies, and diag...
P/S Medical and veterinary preparations, namely, oncological, anti-viral, anti-bacterial and autoimmu...
P/S Medical and veterinary preparations and articles, namely medicines and natural remedies, and dia...
2019 P/S Medical and pharmaceutical products, namely, pharmaceutical preparations for the treatment of onc...
P/S Medical and pharmaceutical products; diagnostic reagents for medical purposes; peptides, protein...
P/S Medical and veterinary pharmaceutical preparations and compositions, namely, medicines and natura...
P/S Pharmaceutical preparations for medical purposes, namely, pharmaceutical preparations for the dia...
P/S Medical and pharmaceutical products, namely, oncological, anti-viral, anti-bacterial and autoimmu...
P/S Medical and pharmaceutical products; diagnostic reagents for medical purposes; peptides, proteins...
2018 P/S Conducting research and clinical trials relating to the use and the engineering of t-cells and ca...
P/S Research and development in the pharmaceutical and biotechnology fields; development of pharmaceu...
P/S Pharmaceuticals; pharmaceutical drugs; pharmaceutical compositions; pharmaceutical preparations....
P/S Medical and veterinary preparations using a combination of medicines and natural remedies, and di...
P/S Pharmaceuticals namely biopharmaceuticals for the treatment of cancer; radioactive pharmaceutical...